Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05043714
Title Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours (NEBULA)
Acronym NEBULA
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors PsiOxus Therapeutics Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Providence Medical Foundation Fullerton California 92835 United States Details
UCLA Department of Medicine Santa Monica California 90404 United States Details
Moffitt-Advent Health Clinical Research Unit Celebration Florida 34747 United States Details
University of Cincinnati Cancer Center Cincinnati Ohio 45267 United States Details
The Clatterbridge Cancer Centre NHS Foundation Trust Liverpool Lancashire L7 8YA United Kingdom Details
Oxford University Hospitals NHS Foundation Trust Oxford Oxfordshire OX3 7LE United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field